I-BET151 inhibits the transcription of BCL2, C-MYC, and CDK6 by interfering with the chromatin recruitment of BRD3/4, which ensures efficacy in different MLL fusion cell lines and impairs the propagation of leukemia stem cells (7, 61). The gene discussed is KMT2A; the disease is leukemia.